Evidence map›Paper›PMID 37452843›Full record

Observational studyEuropean journal of pediatrics2023

The long-term boomerang effect of COVID-19 on admissions for non-COVID diseases: the ECIEN-2022 study.

Beatriz Ramos La Cuey, Neus Saloni-Gomez, Andrea Ilundain López de Munain, Alejandro Fernández-Montero, Natividad Viguria, Leyre López Fernández, Mercedes Herranz Aguirre, Ainhoa Iceta, Laura Moreno-Galarraga

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in European journal of pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Beatriz Ramos La CueyDepartment of Pediatrics, HUN, Hospital Universitario de Navarra, Pamplona, Navarra, Spain.
Neus Saloni-GomezDepartment of Pediatrics, HUN, Hospital Universitario de Navarra, Pamplona, Navarra, Spain.
Andrea Ilundain López de MunainDepartment of Pediatrics, HUN, Hospital Universitario de Navarra, Pamplona, Navarra, Spain.
Alejandro Fernández-MonteroDepartment of Preventive Medicine and Public Health, School of Medicine, University of Navarra, Pamplona, Navarra, Spain.
Natividad ViguriaIdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain.
Leyre López FernándezIdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain.
Mercedes Herranz AguirreDepartment of Pediatrics, HUN, Hospital Universitario de Navarra, Pamplona, Navarra, Spain.
Ainhoa IcetaDepartment of Pediatrics, HUN, Hospital Universitario de Navarra, Pamplona, Navarra, Spain.
Laura Moreno-GalarragaIdiSNA, Navarra Institute for Health Research, Pamplona, Navarra, Spain. laura.moreno.galarraga@navarra.es.ORCID http://orcid.org/0000-0003-0293-0749
Universidad de Navarra · ESNavarre Institute of Health Research · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since COVID-19 pandemic started, many changes have been seen in the cycling patterns of pediatric pathologies. On year 2020, we described the initial effects of COVID-19, with a significant decrease in emergency visits and admissions, but 2 years later the situation seems to be reversed. Our study bridges a literature gap by exploring the lasting effects of COVID-19 on pediatric non-COVID admissions, particularly the resurgence of respiratory illnesses. ECIEN-2022 is a single-center, retrospective, observational-study conducted 3 years after the pandemic onset, to describe the long-term effects of COVID-19 in pediatric admissions for non-COVID diseases. Admissions during year 2022 were compared with the Pre-Pandemic Period (PPP: 2015-2019). Pediatric Emergency Department (P-ED) visits, hospital, and Intensive Care Unit (P-ICU) admissions were compared across pre- and post-pandemic periods. Monthly distribution and year-waves are presented. P-ED monthly visits (mean and Standard deviation (SD) raised from 3521 (533) in the PPP to 3775 (996) in 2022 (p < 0.001). Monthly hospital admissions in the 3rd quarter of the Pre-Pandemic Period were 111.7/month (SD:29), dropped to 88.5(SD:6.5) in 2020 and raised to 149(SD:38.8) in 2022 (p = 0.036). An increase in respiratory illnesses was observed in 2022 compared to PPP; Bronchiolitis increased 38%, bronchitis 56%, and admissions for Respiratory Syncytial Virus 67%.  Conclusion: COVID-19 pandemic has had a significant impact on the use and nature of pediatric health services. The initial decrease has been followed by a boomerang effect with an increase of cases, mainly due to an increase in respiratory infections when pandemic control measures and social restrictions have been lifted. It is essential to maintain an active surveillance and monitorization of these patterns to ensure appropriate healthcare access and utilization. What is Known: • COVID-19 pandemic initially led to a significant decrease in emergency visits and admissions for non-COVID diseases. What is New: • ECIEN-2022 study investigated the long-term effects of COVID-19 on pediatric admissions for non-COVID diseases, detecting a "boomerang effect" with an increase in pediatric admissions for non-COVID diseases in year 2022. • Pediatric Emergency Department visits and hospital admissions for non-COVID diseases, especially those due to respiratory infections, increased significantly in 2022 when compared to the Pre-Pandemic Period.

Indexed as

COVID-19Emergency Service, HospitalHospitalizationPatient AdmissionAdolescentChildChild, PreschoolFemaleHumansInfantMalePandemicsRetrospective StudiesSARS-CoV-2COVID-19HospitalizationLong-term effectsRespiratory infections, SARS-CoV-2

Identifiers

PMID37452843
OpenAlexW4384406747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.